Patents by Inventor Kuai-lin Sun

Kuai-lin Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MCP-1 receptor antagonists and methods of use thereof
    Patent number: 7067538
    Abstract: The present invention relates to sulfones that are useful in the treatment of chemokine-mediated disorders. In certain embodiments, the present invention concerns the compounds that are MCP-1 receptor antagonists.
    Type: Grant
    Filed: May 21, 2003
    Date of Patent: June 27, 2006
    Assignee: Warner-Lambert Company, LLC
    Inventors: Larry D. Bratton, Alexander J. Bridges, David T. Connor, Steven R. Miller, Yuntao Song, Kuai-Lin Sun, Bharat K. Trivedi, Paul C. Unangst
  • Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
    Patent number: 6951848
    Abstract: Disclosed are novel compounds having the formula or a physiologically acceptable salt, amide, ester or prodrug thereof. The compounds can be used to modulate (antagonize, agonize) chemokine receptor function. Also disclosed is a method for treating a patient having an inflammatory disease and/or viral infection comprising administering an effective amount of a compound of Formula I. In particular embodiments, the invention is a method for treating a patient infected with HIV.
    Type: Grant
    Filed: March 12, 2002
    Date of Patent: October 4, 2005
    Assignee: Millennium Pharmaceuticals, Inc.,
    Inventors: Geraldine C. B. Harriman, Kenneth G. Carson, Daniel L. Flynn, Michael E. Solomon, Yuntao Song, Bharat K. Trivedi, Bruce D. Roth, Christine N. Kolz, Ly Pham, Kuai-lin Sun
  • MCP-1 receptor antagonists and methods of use thereof
    Publication number: 20050171163
    Abstract: The present invention relates to sulfones that are useful in the treatment of chemokine-mediated disorders. In certain embodiments, the present invention concerns the compounds that are MCP-1 receptor antagonists.
    Type: Application
    Filed: May 21, 2003
    Publication date: August 4, 2005
    Inventors: Larry Bratton, Alexander Bridges, David Connor, Steven Miller, Yuntao Song, Kuai-Lin Sun, Bharat Trivedi, Paul Unangst
  • N-alkyl pyrroles as HMG-CoA reductase inhibitors
    Publication number: 20050154042
    Abstract: HMGCo-A reductase inhibitor compounds useful as hypocholesterolemic and hypolipidemic compounds are provided. Also provided are pharmaceutical compositions of the compounds. Methods of making and methods of using the compounds are also provided.
    Type: Application
    Filed: December 2, 2004
    Publication date: July 14, 2005
    Inventors: Larry Bratton, Xue-Min Cheng, Chitase Lee, Steven Miller, Jeffrey Pfefferkorn, Toni-Jo Poel, Roderick Sorenson, Yuntao Song, Kuai-Lin Sun, Bharat Trivedi, Paul Unangst
  • Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
    Publication number: 20050075348
    Abstract: Disclosed are novel compounds having the formula or a physiologically acceptable salt, amide, ester or prodrug thereof. The compounds can be used to modulate (antagonize, agonize) chemokine receptor function. Also disclosed is a method for treating a patient having an inflammatory disease and/or viral infection comprising administering an effective amount of a compound of Formula I. In particular embodiments, the invention is a method for treating a patient infected with HIV.
    Type: Application
    Filed: November 8, 2004
    Publication date: April 7, 2005
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Geraldine Harriman, Kenneth Carson, Daniel Flynn, Michael Solomon, Yuntao Song, Bharat Trivedi, Bruce Roth, Christine Kolz, Ly Pham, Kuai-lin Sun
  • Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
    Publication number: 20030064991
    Abstract: Disclosed are novel compounds having the formula 1
    Type: Application
    Filed: March 12, 2002
    Publication date: April 3, 2003
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Geraldine C.B. Harriman, Kenneth G. Carson, Daniel L. Flynn, Michael E. Solomon, Yuntao Song, Bharat K. Trivedi, Bruce D. Roth, Christine N. Kolz, Ly Pham, Kuai-lin Sun